Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Alzheimer's Disease

Trial Information

Have you or someone you love been diagnosed with Alzheimer's Disease?

Clinical Trials of Texas, Inc is participating in a nation-wide study evaluating the effects of a once-a-day nutritional drink on individuals with mild-to-moderate Alzheimer's Disease.

What is the purpose of this study?

The purpose of this study is to test whether a nutritional drink is effective and safe for the dietary management of Alzheimer's Disease.

What will you be asked to do?

You will be asked to consume a nutritional drink once every day for a period of 6 months. During this time, you will be regularly monitored and tested by study staff for any changes in your memory and thinking abilities.

To be eligible to participate in this study, you must be:

• Clinically diagnosed with mild-to-moderate Alzheimer's Disease
• Taking an FDA approved medication for Alzheimer's Disease (Aricept, Exelon, Razadyne, and/or Namenda) for the past 4 months.
• 50 years of age or older
• Not previously diagnosed with vasculare dementia, Huntington's Disease, Parkinson's Disease or seizures
• Not living in a nursing home
• Able to have a caregiver or study partner be with you during all study visits and telephone calls

Tracy Critchfield, MSM, Marketing/Recruitment Specialist
Clinical Trials of Texas, Inc.
7940 Floyd Curl Dr., Suite 700
San Antonio, TX 78229
Phone: 210.949.0122
Fax: 210.949.0181

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.